Exogenous hydrogen sulfide attenuates diabetic myocardial injury through cardiac mitochondrial protection

Molecular and Cellular Biochemistry

Volumn 371, Issue 1-2, 2012, Pages 187-198

  Zhong, Xin ^a   Wang, Leihong ^a   Wang, Yuwen ^a   Dong, Shiyun ^a   Leng, Xiaoning ^a   Jia, Jing ^a   Zhao, Yajun ^a   Li, Hulun ^a   Zhang, Xinying ^a   Xu, Changqing ^a   Yang, Guangdong ^b   Wu, Lingyun ^b   Wang, Rui ^b   Lu, Fanghao ^a   Zhang, Weihua ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b LAKEHEAD UNIVERSITY   (Canada)

Author keywords

Diabetic myocardial injury; Hydrogen sulfide; Mitochondrial; Nitric oxide

Indexed keywords

CASPASE 3; CASPASE 9; CYTOCHROME C; HYDROGEN SULFIDE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART MITOCHONDRION; HEART MUSCLE INJURY; HYPERGLYCEMIA; MALE; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; SARCOMERE;

ANIMALS; CASPASE 3; CYSTATHIONINE GAMMA-LYASE; CYTOCHROMES C; DIABETES MELLITUS, EXPERIMENTAL; HYDROGEN SULFIDE; MALE; MITOCHONDRIA; MYOCARDIUM; MYOCYTES, CARDIAC; NADPH OXIDASE; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES;

RATTUS;

EID: 84868550804     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1435-3     Document Type: Article

References (35)

1. Cai L, Wang Y, Zhou G, Chen T, Song Y, Li X et al (2006) Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. J Am Coll Cardiol 48:1688-1697
2. Cai L (2006) Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy. Free Radic Biol Med 41:851-861
3. Barouch LA, Berkowitz DE, Harrison RW, O'Donnell CP, Hare JM (2003) Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation 108:754-759
4. Wold LE, Ren J (2004) Streptozotocin directly impairs cardiac contractile function in isolated ventricular myocytes via a p38 map kinase dependent oxidative stress mechanism. Biochem Biophys Res Commun 318:1066-1071
5. Cai L, Li W, Wang G, Guo L, Jiang Y, Kang YJ (2002) Hyperglycemia induced apoptosis in mouse myocardium: mitochondrial cytochrome c-mediated caspase-3 activation pathway. Diabetes 51:1938-1948
6. Brownlee M (1995) Advanced protein glycosylation in diabetes and aging. Annu Rev Med 46:223-234
7. Russell LK, Mansfield CM, Lehman JJ, Kovacs A, Courtois M, Saffitz JE et al (2004) Cardiac specific induction of the transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator-1 alpha promotes mitochondrial biogenesis and reversible cardiomyopathy in a developmental stage-dependent manner. Circ Res 94:525-533
8. An D, Rodrigues B (2006) Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 291:H1489-H1506
9. Shah AM, MacCarthy PA (2000) Paracrine and autocrine effects of nitric oxide on myocardial function. Pharmacol Ther 86:49-86
10. Xie YW, Wolin MS (1996) Role of nitric oxide and its interaction with superoxide in the suppression of cardiac muscle mitochondrial respiration. Involvement in response to hypoxia/reoxygenation. Circulation 94:2580-2586
11. Li H, Forstermann U (2000) Nitric oxide in the pathogenesis of vascular disease. J Pathol 190:244-254
12. Zhuo Y, Chen PF, Zhang AZ, Zhong H, Cheng CQ, Zhu YZ (2009) Cardioprotective effect of hydrogen sulfide in ischemic reperfusion experimental rats and its influence on expression of survivin gene. Biol Pharm Bull 32:1406-1410
13. Zhong G, Chen F, Cheng Y, Tang C, Du J (2003) The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase. J Hypertens 21:1879-1885
14. Zhang C, Du J, Bu D, Yan H, Tang X, Tang C (2003) The regulatory effect of hydrogen sulfide on hypoxic pulmonary hypertension in rats. Biochem Biophys Res Commun 302:810-816
15. Li X, Du J, Lin S, Li J, Tang X, Qi J et al (2005) Down-regulation of endogenous hydrogen sulfide pathway in pulmonary hypertension and pulmonary vascular structural remodeling induced by high pulmonary blood flow in rats. Circ J 69:1418-1424
16. Aplin M, Christensen GL, Schneider M, Heydorn A, Gammeltoft S, Kjolbye AL et al (2007) The angiotensin type 1 receptor activates extracellular signal-regulated kinases 1 and 2 by G protein-dependent and-independent pathways in cardiac myocytes and langendorff-perfused hearts. Basic Clin Pharmacol Toxicol 100:289-295
17. Di LF, Blank PS, Colonna R, Gambass G, Silverman HS, Stern MD et al (1995) Mitochondrial membrane potential in single living adult rat cardiac myocytes exposed to anoxia or metabolic inhibition. J Physiol 486:1-13
18. 2+ handling in adult control and ob/ob cardiomyocytes: impact of mitochondrial reactive oxygen species. Diabetes 56:1136-1142
19. Kojima H, Urano Y, Kikuchi K, Higuchi T, Hirata Y, Nagano T (1999) Fluorescent indicators for imaging nitric oxide production. Angew Chem Int Ed Engl 38:3209-3212
20. Zhang W, Fu S, Lu F, Wu B, Gong D, Pan Z et al (2006) Involvement of calcium-sensing receptor in ischemia/reperfusion-induced apoptosis in rat cardiomyocytes. Biochem Biophys Res Commun 347:872-881
21. Heinzel FR, Luo Y, Dodoni G, Boengler K, Petrat F, Di Lisa F et al (2006) Formation of reactive oxygen species at increased contraction frequency in rat cardiomyocytes. Cardiovasc Res 71:374-382
22. Boudina Sihem, Dale Abel E (2007) Diabetic cardiomyopathy revisited. Circulation 115:3213-3223
23. Gorin Y, Block K, Hernandez J, Bhandari B, Wagner B, Barnes JL et al (2005) Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem 280:39616-39626
24. Block K, Gorin Y, Abboud HE (2009) Subcellular localization of Nox4 and regulation in diabetes. Proc Natl Acad Sci 106:14385-14390
25. 2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 322:587-590
26. Kimura Y, Kimura H (2004) Hydrogen sulfide protects neurons from oxidative stress. FASEB J 18:1165-1167
27. Whiteman M, Armstrong JS, Chu SH, Jia-Ling S et al (2004) The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger'? J Neurochem 90:765-768
28. Geng B, Chang L, Pan C, Qi Y, Zhao J, Pang Y, Du J, Tang C (2004) Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun 318:756-763
29. Narula J, Pandey P, Arbustini E, Haider N, Narula N, Kolodgie FD et al (1999) Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci 96:8144-8149
30. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA (1993) Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 88:2510-2516
31. Ding Y, Vaziri ND, Coulson R, Kamanna VS, Roh DD (2000) Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression. Am J Physiol Endocrinol Metab 279:E11-E17
32. Joffe II, Travers KE, Perreault-Micale CL, Thomas H, Katz SE, Morgan JP et al (1999) Abnormal cardiac function in the streptozotocin-induced, non-insulin-dependent diabetic rat. J Am Coll Cardiol 34:2111-2119
33. Bucci M, Papapetropoulos A, Vellecco V, Zhou Z, Pyriochou A, Roussos C et al (2010) Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity. Arterioscler Thromb Vasc Biol 30:1998-2004
34. ATP channel opener. EMBO J 20:6008-6016
35. Wang R (2012) Physiological implications of hydrogen sulfide: a whiff exploration that blossomed. Physiol Rev 92:791-896